Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Cancer Discovery
Published October 19, 2026
H3K4me1-Mediated Epigenomic Priming of Chemoresistant Tumor States in Ovarian Cancer.
October 20, 2026
Medspoke
Medspoke
Clinical Cancer Research
Published October 19, 2026
00:00
--:--
When the Tumor Disappears, Must the Larynx Follow?
October 20, 2026
Share
When the Tumor Disappears, Must the Larynx Follow?
https://www.medspoke.co/channel_journal?id=686&tap_id=15940
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Clinical Infectious Diseases (CID)
Published October 19, 2026
Not All Extrapulmonary Tuberculosis Is Equal: Site-Specific Mortality in a National Indian Cohort.
October 20, 2026
Why are you reporting this TALK?
